The pathologist in tortland: when is ignorance about 'med-mal' rational, when is it unavoidable, and when is it a problem to be corrected?

摘要

This article reviews the current concepts regarding the clinicopathologic features of triple-negative breast carcinoma, its histologic subtypes, molecular classification, the prognostic and therapeutic potential of biomarkers, and emerging targeted therapies.